CALM1 and glioblastoma: KM survival analysis showed that patients with elevated CALM1 expression had a favorable OS in KIRC, SARC, glioblastoma multiforme and brain lower-grade glioma (GBMLGG), and COAD, but poorer OS in uveal melanoma (UVM), acute myeloid leukemia (LAML) and BLCA (Figure 5A).